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Abstract 
Although schizophrenia (SZ) and bipolar disorder (BD) share some clinical features 
such as psychotic symptoms and cognitive dysfunctions, little is known about possible 
pathophysiological similarities between both diseases. Therefore, we investigated the 
potential topographical overlap and segregation of cortical thickness abnormalities in SZ and 
BD patients.  
We analyzed 3D-anatomical magnetic resonance imaging datasets with the FreeSurfer 
5.1.0 software to examine cortical thickness and volumes in three groups of participants: n = 
34 BD patients, n = 32 SZ patients and n = 38 healthy controls.  
We observed similar bilateral cortical thickness reductions in BD and SZ patients 
predominantly in the pars opercularis of the inferior frontal gyrus and in the anterior and 
posterior cingulate. We also found disease-specific cortical reductions in the orbitofrontal 
cortex for BD patients and in dorsal frontal and temporal areas for SZ. Furthermore, inferior 
frontal gyrus cortical thinning was associated with deficits in psychomotor speed and 
executive functioning in SZ patients and with age at onset in both groups. 
Our findings support the hypothesis that thinning of the frontal cortex may represent a 
biological feature shared by both disease groups. The associations between cognitive deficits 
and the reported findings in SZ and to a lesser degree in BD patients add to the functional 
relevance of our results. However, further studies are needed to corroborate a model of shared 
pathophysiological disease features across BD and SZ.  
1. Introduction
A major goal of recent structural imaging studies in schizophrenia (SZ) and bipolar disorder 
(BD) patients has been to detect potential overlap in structural and functional imaging 
markers. According to some studies, both diseases share frontal and subcortical abnormalities, 
which supports the spectrum-hypothesis of psychotic disorders (Ellison-Wright and Bullmore, 
2010). However, other studies suggest that grey matter (GM) density reductions are unique to 
SZ (see i.e. Hirayasu et al., 2001) and support Kraepelin’s dichotomy concept (Kraepelin, 
1919). Only few researchers compared cortical thickness between SZ and BD patients directly 
(Hulshoff et al., 2012; Rimol et al., 2012). Those who did proposed a similarity in cortical 
thinning mainly in frontal regions (Rimol et al., 2012). Rimol and colleagues suggested that 
SZ patients are affected more severely than BD patients, showing more widespread temporal, 
occipital and parietal volume reductions and a decrease in cortical thickness (Rimol et al., 
2012). Hulshoff and colleagues compared shared and segregated brain abnormalities in 
patients with SZ and BD and suggested that a smaller volume of overlapping white matter 
(WM) and common areas of thinner cortex indicated that both disorders share genetic and 
neurodevelopmental pathways (Hulshoff et al., 2012). Furthermore, Janssen and colleagues 
observed frontal thinning in adolescents with BD and SZ (Janssen et al., 2014). 
Current knowledge indicates that deficits in several cognitive domains may be 
associated with cortical thinning in SZ (Ehrlich et al., 2012; Hartberg et al., 2010; Oertel-
Knöchel et al., 2012) and BD (Gutierrez-Galve et al., 2011). In BD, significant associations 
have been reported between course of illness and sociodemographic variables, such as gender 
(Najt et al., 2007) or age (Brambilla et al., 2001; Lyoo et al., 2006) and cortical thickness in 
temporal lobes (for episodes of illness, see (Moorhead et al., 2007)) and in frontal lobes (for 
years of illness, see (Lyoo et al., 2006). Padmanabhan et al. assessed a large sample of 
schizophrenia, schizoaffective and bipolar I patients (n = 455) and observed that positive 
symptoms of psychosis were significantly associated with reductions in cortical thickness in 
frontal and temporal areas across groups, and that negative symptoms correlated with right 
frontal cortex thinning (Padmanabhan et al., 2014). However, the functional relevance of 
structural abnormalities may depend on which symptoms or cognitive domains are being 
assessed (Gutierrez-Galve et al., 2011; Lyoo et al., 2006; Rimol et al., 2010).  
In the current study we directly compared cortical thickness and volumes in BD and 
SZ patients to healthy controls. As a main hypothesis, we suggest that SZ and BD share 
frontal cortical thinning and volume reductions. Additionally, we suggest that decreases in 
cortical thickness are directly associated with cognitive and clinical features of psychosis.
2. Material and Methods
2.1 Participants 
We examined 32 SZ patients (Mage = 39.56 years (SD= 10.90)), 34 euthymic BD I patients 
(Mage = 43.93 years (SD= 10.87)) and 38 healthy controls (Mage = 40.86 years (SD = 11.91)). 
All patients were treated as outpatients at the time of the study and had been in remission for a 
minimum of one month. None of the patients had any comorbid axis I or II disorder 
(including substance abuse or addiction). To confirm the diagnoses in the patient groups and 
to ensure that none of the control participants was affected by a psychiatric disorders 
according to DSM-IV (APA, 1994) we conducted the Structured Clinical Interview for DSM 
IV Disorders (SCID-I and SCID-II; German version; (Wittchen et al., 1996)). The controls 
had no family history of affective disorder or psychosis. The three groups were matched for 
handedness (all were right handed as assessed using the Edinburgh Handedness Inventory, 
(Oldfield, 1971)), age, gender and years of education. The two patient groups were matched 
for duration of disease and age at disease onset.  
Crystallized intelligence was assessed using the German equivalent of the “Spot-the-
Word test” (Mehrfachwahl-Wortschatz-Intelligenz-Test ((MWT-B; (Lehrl, 2005). 
Psychomotor speed and executive functioning were tested using the Trail-Making test (TMT 
A and TMT B (Reitan et al., 1988).  
Current psychopathological symptoms in SZ patients were assessed using the Positive 
and Negative Syndrome Scale (PANSS; (Kay et al., 1987)) and the Revised Hallucination 
Scale (RHS; (Morrison et al., 2002)). We applied the remission criteria defined by (Andreasen 
et al., 2005). To define remission, we used the following PANSS (Kay et al., 1987) items: 
delusions, unusual thought content, hallucinations, conceptual disorganization, mannerisms 
and posturing, blunted affect, social withdrawal and lack of spontaneity. According to the 
criteria by Andreasen et al., the ratings of these items had to be mild or less over a 6-month 
period (Andreasen et al., 2005). For the euthymic BD patients we evaluated symptom severity 
using the German version of the Beck Depression Inventory (BDI II; (Hautzinger et al., 2006) 
for depressive symptoms (BDI II score of < 10) and the German version of the Bech-
Rafaelsen Mania Scale (BRMAS; (Bech, 1981)) for mania symptoms (BRMAS score of < 7).  
All patients had been on stable medication for at least four weeks prior to 
measurement (see Supplemental Material Table S1 for further details). None of the BD or SZ 
patients received any benzodiazepines and none of them were without medication. To 
compare different substances and doses, chlorpromazine (see the formula by (Woods, 2003)) 
and amitryptiline equivalents (Ali, 1998) were computed.  
2.2 Data Acquisition and Image Processing 
MRI measurements took place at the Goethe-University Brain Imaging Center, Frankfurt, 
Germany. We acquired a high-resolution, T1-weighted MDEFT sequence (Deichmann et al., 
2004) for anatomical brain imaging (176 slices, 1x1x1 mm, matrix size 256*256, slice 
thickness 1mm, flip angle: 16°) covering the entire brain of each participant on a Siemens 
Magnetom Allegra 3 Tesla MRI system (Siemens Medical Systems, Erlangen, Germany). All 
anatomical T1-weighted MRI scans were reviewed by a neuroradiologist who did not find any 
neurological or other pathology (i.e. focal or local atrophy, lacunar infarctions or extensive 
microangiopathy).  
Analysis of structural MRI data was performed using the software tools of 
MATLAB® (The Mathworks Inc., Natick, MA, USA), FreeSurfer® (Version 5.1.0) 
(FreeSurfer Troubleshooting Reconstruction Work Flow; http://surfer.nmr.mgh.harvard.edu/) 
and a FreeSurfer application (Qdec®).  
2.3 Data Preprocessing 
Cortical thickness was estimated at each vertex across the brain surface using the semi-
automated approach of the FreeSurfer 5.1.0 software (Dale et al., 1999; Fischl et al., 1999). 
This procedure included reconstruction of the grey matter (GM) - white matter (WM) 
boundary and the cortical surface (Dale et al., 1999; Han and al., 2006; Rosas, 2002), a 
calculation of the distance between those surfaces at each point across the cortical mantle 
(Dale et al., 1999), a transformation of all data into the Talairach space and an automatic 
stripping of the skull and subcortical structures (see (Segonne et al., 2004)). The smoothing 
algorithm by (Dale et al., 1999) was used to alleviate the voxel-based nature of the initial 
curvature and potential topological defects were corrected using an automated topology fixer 
(see (Segonne et al., 2005)). The anatomies were further registered to a reference brain (an 
average template that included anatomical data sets) to visualize the results. The surfaces were 
spherically inflated and registered to a common space spherical deformation guided by 
automatically defined cortical features that were derived from a population atlas (Fischl et al., 
1999). The resulting surfaces were transferred to Talairach space, allowing direct, 
anatomically accurate measurements of thickness. For quality control, all segmentations were 
inspected, manually corrected and re-inspected as described by (Fischl et al., 2001) and 
(Goldman et al., 2009).  
We used the resulting surfaces to compile all surface data into 33 cortical regions of 
interest (see (Desikan et al., 2006; Fischl et al., 2001)). Each subject’s reconstruction was 
again visually inspected for gross topological inaccuracies. Cortical thickness was calculated 
for each vertex in the triangulated surfaces by finding the point on the white matter surface 
that was closest to a given point of the pial surface (and vice versa) (Fischl and Dale, 2000; 
Han and al., 2006). An average normal control surface was generated and thickness data from 
each subject were smoothed using a standard Gaussian filter and mapped to the average 
surface.  
2.4 Statistical Analysis 
Extracted values for cortical thickness and volumes as provided by the QDEC® application.of 
all participants were fitted into three independent ANCOVA models as independent variables, 
with patient diagnosis (CON, BD, SZ) as a fixed factor and intracranial volumes (ICV) as a 
covariate. We also conducted independent ANOVAs to compute group comparisons of 
cognitive and clinical data. All group differences were deemed significant on a threshold level 
of p < 0.05 after a correction for multiple comparisons using the false discovery rate (pFDR;
(Genovese et al., 2002)). 
We performed bivariate correlation analyses (Spearman rank correlation, 2-tailed; 
(Pearson product moment correlation, 2-tailed) between all structural imaging parameters that 
differed significantly between groups and cognitive, clinical and course of illness variables. 
We also conducted bivariate correlation analyses between the thickness values and the 
medication scores as well as years of medication. All correlation analyses were corrected for 
multiple comparisons using the Bonferroni correction (pBonf). 
3. Results
3.1 Statistical Comparisons of Cognitive and Clinical Data 
Statistical tests revealed no significant group differences in age, gender and years of 
education (p > 0.05). The scores of the BDI II differed significantly between BD patients and 
controls (z = 15.65, p = 0.001), indicating some residual subclinical depressive symptoms in 
patients. There were no group differences regarding the BRMAS scores (z = 1.41, p > 0.05), 
showing that manic symptoms had remitted completely. SZ patients had higher scores in the 
RHS values (predisposition towards hallucinations) in comparison with controls (z = 11.82, p 
< 0.01). The cognitive and clinical data are documented in Table 1. 
In the cognitive tests, the MWT-B values (crystallized intelligence) did not differ 
significantly across groups (F = 1.62, p > 0.05). The scores of the TMT A (psychomotor 
speed) showed significant group differences between controls and SZ patients (F = 3.82, p < 
0.05) indicating poorer performance in SZ patients, but no significant differences between 
controls and BD patients or between BD patients and SZ patients (all p > 0.05). In the TMT B 
(executive functioning), SZ patients showed significantly poorer performance than BD 
patients and controls (F = 32.72, p < 0.001). However, BD patients and controls did not differ 
significantly (p > 0.05).  
3.2 Statistical Comparisons of Structural Imaging 
There were significant group differences in cortical thickness parameters in the 
following brain regions: bilateral medial orbitofrontal gyrus, bilateral pars opercularis of the 
inferior frontal gyrus, left rostral middle frontal gyrus, right cuneus, right inferior temporal 
gyrus and right rostral anterior cingulate (pFDR < 0.05).
Group comparisons of volume parameters indicated significant group differences in 
the left medial orbitofrontal gyrus, in the right pars opercularis of the inferior frontal gyrus, in 
the right superior frontal gyrus, in the right rostral middle frontal gyrus and in the left insula. 
Post-hoc group comparisons revealed lower thickness parameters in the pars 
opercularis bilaterally (thickness: left and right; volume: right), in the left rostral anterior 
cingulate thickness, in the right cuneus cortical thickness in SZ and BD patients in 
comparison with controls (p (FDR) < 0.05; see Table 2, Figure 2 for further details).  
In the left rostral middle frontal gyrus, we observed significantly decreased volume 
and thickness in SZ patients compared with BD patients and controls. Moreover, right inferior 
temporal gyrus thickness and volume were significantly lower in SZ patients compared with 
BD patients and controls (pFDR < 0.05; see Table 2). SZ patients had significantly lower left 
superior frontal gyrus volumes in comparison with controls (pFDR < 0.05), with BD patients 
showing no significant group differences to either SZ patients or controls (pFDR > 0.05).
BD patients showed a significant reduction of left medial orbitofrontal gyrus thickness 
and right medial orbitofrontal gyrus thickness and volume as compared to controls (pFDR < 
0.05). However, SZ patients did not differ significantly from the other groups in any of these 
values (pFDR > 0.05).
3.3 Correlation Analysis 
Lower thickness of the left pars opercularis (inferior frontal gyrus) was significantly 
associated with earlier age at onset, lower psychomotor speed (TMT A) and executive 
functioning (TMT B) in SZ patients (pBonf <0.05). In both disorders, there was a significant 
inverse association between left medial orbitofrontal gyrus thickness and age at onset. None 
of the structural imaging parameters were significantly correlated with PANSS scores, 
duration of disease, medication dose equivalents or years of medication (pBonf > 0.05).  
There was no significant association of cognitive, clinical and cortical thickness 
parameters in the control group (pBonf > 0.05; see Table 3 for further details).   
4. Discussion
Our study showed predominantly frontal (pars opercularis of the inferior frontal gyrus 
bilaterally) and limbic (rostral anterior cingulate, posterior cingulate) thinning of the cortical 
sheet in BD and SZ patients in comparison with controls. The results are in line with previous 
structural imaging findings suggesting comparable changes in SZ and BD patients, 
predominantly in the frontal and temporal lobes and cingulate gyrus (for BD, see (Bouras et 
al., 2001; Foland-Ross et al., 2011; Fornito et al., 2008; Fornito et al., 2009; Lyoo et al., 
2006; Oertel-Knochel et al., 2015; Qiu et al., 2008); for SZ, see (Goldman et al., 2009; 
Haukvik et al., 2009; Kuperberg et al., 2003; Lawyer et al., 2008; Venkatasubramanian et al., 
2008)). This may indicate shared pathophysiological mechanisms in BD and SZ 
(Craddock and Owen, 2005) (Craddock and Owen, 2010) and would contradict 
Kraepelin’s suggestion that both disorders are entirely independent disease entities 
(Kraepelin, 1919).  
However, the left rostral middle frontal gyrus and the right inferior temporal gyrus (in 
SZ) and the bilateral orbitofrontal cortices (in BD) were affected selectively. In fact, there 
were graded changes from SZ to BD to CON in the left superior frontal gyrus volumes and in 
the right cuneus thickness. These findings support the hypothesis that segregated cortical 
abnormalities may represent correlates of different symptom clusters in BD and SZ. For 
instance, the orbitofrontal cortex is known to be involved in emotion and reward in decision 
making (Kringelbach, 2005). Cortical thinning in this area specific to BD patients might thus 
be related to the affective component of this disorder. In contrast, the middle frontal cortex is 
a core structure of executive functioning, a cognitive domain which is strongly affected in SZ. 
In future studies it may be of interest to examine the functional specifications of the regions 
under scrutiny to show differences across patient groups and to investigate whether specific 
brain alterations are associated with distinct symptom patterns in BD and SZ.  
Functional significance of structural imaging findings 
Our observation of significant associations between age of onset and frontal cortex 
thinning (left medial orbitofrontal gyrus, pars opercularis) suggests that loss of cortical 
volume may be progressive in BD and in SZ. Significant associations between course of 
illness, sociodemographic variables and cortical thickness in the temporal and frontal lobes 
have been reported before (Brambilla et al., 2001; Lyoo et al., 2006; Najt et al., 2007). With 
our cross-sectional design we cannot answer the question whether cortical thinning in 
psychosis is caused by neurodevelopmental or neurodegenerative factors. The fact that 
cortical thinning in our ROIs was not significantly connected with duration of illness would 
make neurodegenerative factors less likely but longitudinal designs would be needed in order 
to distinguish neurodevelopmental from neurodegenerative processes.   
In SZ, higher psychomotor speed (TMT A) and executive functioning (TMT B) were 
directly related with frontal cortex thinning but not with clinical variables. This confirms 
previous findings by our work group and others (Ehrlich et al., 2012; Ehrlich et al., 2010; 
Hartberg et al., 2010; Hartberg et al., 2011; Oertel-Knöchel et al., 2012) that show correlations 
between frontal cortical thinning and performance deficits in SZ.  
Limitations 
Potential influence of psychopharmacological treatment on structural imaging markers 
may not be completely ruled out, although we observed no significant association between 
medication load and cortical thickness measures. Several groups suggested either no influence 
or that an increased volume correlated with the dosage of psychopharmacological treatment 
(Dazzan et al., 2005; Hafeman et al., 2012b; Hafeman et al., 2012a; Phillips et al., 2008). 
Particularly, lithium therapy in BD patients has been associated with increases in cortical 
volume on MRI scans (Moore et al., 2000). Antipsychotics in SZ and BD may cause changes 
in cortical thickness dependent on the type of antipsychotics: typicals were associated with an 
increased volume of the putamen and a decreased volume of cortical areas; atypical  
antipsychotics have been observed to be associated with an enlargement of the thalami 
(Dazzan et al., 2005; Moncrieff and Leo, 2010).  
We have to emphasize that only non-acute SZ or euthymic BD patients were enrolled 
in our study, resulting in relatively low symptom severity scores (Bremner et al., 2002; 
Lacerda et al., 2004; Lai et al., 2000). In future studies, non-acute and acute patients need to 
be directly compared to test for possible relations of clinical severity with cortical thickness. 
Moreover, we did not directly test clinical similarities, for example, psychotic or affective 
symptoms, across patients groups. As we conducted different neuropsychological scales to 
assess individual psychopathology (BDI II, BRMAS in BD; PANSS in SZ), we had no 
possibility to directly compare affective symptoms in BD and SZ. However, the PANSS 
interview done with SZ patients includes several items referring to the affective state or to 
depressive symptoms of the patients, that are hyperactivity (P4), grandiosity (P5), Blunted 
affect (N1), emotional withdrawal (N2), poor rapport (N3), passive/apathetic social 
withdrawal (N4), Depression (G6) and active social avoidance (G16). Psychotic symptoms 
were examined in BD patients using the BRMAS. However, we did not observed associations 
between individual psychopathology and structural markers in either BD or SZ.  
Conclusions 
We report that BD and SZ share cortical thinning in the pars opercularis of the inferior 
frontal gyrus bilaterally and the anterior and posterior cingulate bilaterally (left: anterior; 
right: posterior). Frontal cortical thinning has been associated with deficits in psychomotor 
speed and executive functioning in SZ and age of onset in SZ and BD. However, we also 
reported segregated alterations between both patient groups, which indicate distinct 
pathophysiological patterns across BD and SZ.  
The detection of overlap, as suggested by (Craddock and Owen, 2005), and 
distinction, as suggested by (Kraepelin, 1919) contribute to and modify the 
neurophysiological models of psychotic disorders and may help to clarify the pathways that 
contribute to individual symptom patterns (Linden, 2012). Further studies are needed to 
elucidate and corroborate a model of shared pathophysiological disease features across BD 
and SZ and should incorporate additional analysis techniques, such as network-level 
approaches (Wheeler et al., 2015).  
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Table 1: Sociodemographic and clinical characteristics and cognitive performance across 
groups. SD values are in brackets. Abbreviations: CON = healthy controls, BD = bipolar 
patients, SZ = schizophrenia patients, BDI II = Beck Depressions Inventory, BRMAS = Bech-
Rafaelsen Mania Scale, TMT = Trail Making Test, RHS = Revised Hallucination Scale, 
PANSS = Positive and Negative Syndrome Scale, MWT-B = Multiple-choice-word-
comprehension-test *: p = significant on a < 0.05-threshold, **: p = significant on a < 0.01-
threshold, ***: p = significant on a < 0.001-threshold, ns = not significant. a: defined as the
timespan between first hospitalization and study participation. 
Variable CON BD SZ Significance 
Number 38 34 32 - 
Gender 
f / m 15 / 23 15 / 19 16 / 16 
χ² = 0.21, ns 
(Chi-square) 
Age (years) 40.86 (11.91) 21-59 
43.93 (10.87) 
19-58 
39.56 (10.90) 
20-57 F = 2.34, ns 
Education 
(years) 15.70 (1.80) 15.47 (1.74) 14.69 (2.78) F = 2.19, ns 
Handedness All right handed - 
Duration of disease 
(years)a 
- 9.76 (6.65) 9.33 (5.31) t = 0.04, ns 
Number of episodes 
of illness 
- depressive: 6.13 
(2.34) 
manic: 3.56 
(1.23) 
4.25 (1.23) - 
Age of onset (years) - 31.00 (10.37) 27.17 (9.55) t = 1.21, ns 
BDI II 2.11 (2.10) 9.58 (9.27) - z = 5.65*** 
BRMAS 1.45 (1.12) 2.10 (2.75) - z = 1.41, ns 
RHS 25.29 (4.19) 
- 
34.57 (9.47) z = 11.82** 
PANSS - 
- 
PANSS pos: 17.01 (5.34) 
PANSS neg: 17.88 (5.87) 
PANSS gen: 33.01 (8.49) 
PANSS sum: 66.85 (8.34) 
TMT A 27.32 (9.27) 
CON / BD: ns 
35.28 (10.56) 
BD / SZ: ns 
42.41 (29.09) 
CON / SZ: * 
F = 3.82* 
TMT B 40.70 (7.25) 
CON / BD: ns 
51.67 (7.25) 
BD / SZ: *** 
140.71 (10.62) 
CON / SZ: *** 
F = 32.72*** 
MWT-B 30.53 (3.07) 30.40 (3.15) 28.28 (5.19) F = 1.62, ns 
Table 2: The table contains all regions which showed significant differences in cortical 
thickness and volumes across groups (group contrast; left column; FDR corrected). 
Abbreviations: CON = healthy controls, BD = bipolar patients, SZ = schizophrenia patients, T 
= cortical thickness, V = volume, IFG = inferior frontal gyrus. *: p = significant on a < 0.05-
threshold, **: p = significant on a < 0.01-threshold, ***: p = significant on a < 0.001-
threshold, ns = not significant. 
Group comparisons 
Region (area) Hemisphere Mean [mm], SD F               
(df= 
99) 
p Post-hoc test 
pars opercularis 
(IFG) T 
left CON: 2.15 (0.05) 
BD: 1.69 (0.34)            
SZ: 1.63 (0.21) 
4.99 0.009 CON / BD*                  
CON / SZ** 
right CON: 2.16 (0.05) 
BD: 2.09 (0.17)            
SZ: 1.89 (0.25) 
4.99 0.009 CON / SZ**                 
CON / BD* 
pars opercularis 
(IFG) V 
right CON: 473.12 (1.08) 
BD: 443.45 (1.03)         
SZ: 401 (1.00) 
1.31 0.04 CON / SZ***               
CON / BD*** 
rostral anterior 
cingulate T 
left CON: 3.44 (0.71) 
BD: 2.79 (0.48)   
SZ: 2.35 (0.44) 
CON / SZ**
CON / BD* 
Cuneus T right CON: 1.811 (0.66) 
BD: 1.486 (0.16)   
SZ: 1.343 (0.37) 
3.08 0.05 CON / BD* 
CON / SZ* 
Superior frontal 
gyrus V 
left CON: 2245.37 
(392.56) 
BD: 2127.81 (341.35) 
SZ: 2001.35 (243.34) 
3.05 0.05 CON / SZ** 
rostral middle 
frontal gyrus T 
left CON: 2.32 (0.29) 
BD: 2.26 (0.56) 
SZ: 1.79 (0.17) 
5.30 0.007 CON / SZ*                          
SZ / BD* 
rostral middle 
frontal gyrus V 
left CON: 4056.56 
(668.16)        
BD: 3981.36 (745.14) 
SZ: 3765.15 (574.51) 
4.05 0.004 CON / SZ**                 
SZ / BD** 
inferior temporal 
gyrus T 
right CON: 2.51 (1.94) 
BD: 2.23 (1.02) 
SZ: 2.03 (1.00) 
6.65 0.002 CON / SZ**                       
SZ / BD* 
Inferior temporal 
gyrus V 
right CON: 10488.90 
(2172.46) 
BD: 10132.33 
(1823.23) 
SZ: 10050.28 
(1564.57) 
3.58 0.03 CON / SZ*                  
SZ / BD* 
medial orbitofrontal 
gyrus T 
left CON: 2.27 (0.08) 
BD: 1.86 (0.11) 
SZ: 1.99 (0.17) 
3.14 0.04 CON / BD* 
right CON: 2.21 (0.17) 
BD: 1.75 (0.07) 
SZ: 1.95 (0.12) 
3.12 0.04 CON  / BD* 
medial orbitofrontal 
gyrus V 
left CON: 4199.85 
(672.11)   
BD: 3972.34 (733.23) 
SZ: 4013.23 (574.23) 
3.54 0.03 CON / BD* 
Table 3: The table contains all significant correlations (Spearman rank correlation (rho; two-
tailed). Abbreviations: BD = bipolar patients, SZ = schizophrenia patients, T = cortical 
thickness, l = left, TMT = Trail Making Test. *: p = significant on a < 0.05-threshold, **: p = 
significant on a < 0.01-threshold, ***: p = significant on a < 0.001-threshold.  
Significant correlations 
CON BD SZ 
l. medial
orbitofrontal 
gyrus T 
Age at onset: 
rho = 0.54** 
Age at onset: rho = 0.61**
l. pars
opercularis of 
the inferior 
frontal gyrus T 
TMT A:rho=-0.21, ns      
TMT B:rho=-0.12, ns 
TMT A: rho=-0.39, ns     
TMT B: rho=-0.41, ns 
Age of onset: rho = 0.73**
TMT A: rho = -0.52**    
TMT B: rho = -0.84*** 
Figure legend: 
Figure 1: Statistical group comparisons (F-test) between all groups in cortical thickness 
values of the left (l) medial orbitofrontal gyrus thickness (T) and the left (l) pars opercularis of 
the inferior frontal gyrus thickness (T). Moreover, the image presents significant correlations 
between the structural imaging data and cognitive and clinical variables. Abbreviations: 
TMT=Trail making Test, CON= controls, BD = bipolar patients, SZ = schizophrenia patients.  
Figure 2: Overlapped or distinct patterns of structural abnormalities across patient groups. 
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